Analytic Investors’s Cardinal Health CAH Stock Holding History

Analytic Investors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$77.6M	Buy	999,068 +161,334	+19%	+$13M	0.87%	32
2016 Q2	$65.4M	Sell	837,734 -279,726	-25%	-$22.3M	0.77%	40
2016 Q1	$91.6M	Buy	1,117,460 +53,936	+5%	+$4.39M	1.12%	22
2015 Q4	$94.9M	Sell	1,063,524 -462,059	-30%	-$39.2M	1.19%	21
2015 Q3	$117M	Buy	1,525,583 +861,126	+130%	+$72M	1.57%	17
2015 Q2	$55.6M	Buy	664,457 +51,483	+8%	+$4.55M	0.78%	40
2015 Q1	$55.3M	Buy	612,974 +285,720	+87%	+$24.6M	0.76%	41
2014 Q4	$26.4M	Buy	+327,254	New	+$25.8M	0.38%	81
2014 Q2	–	Sell	-791,210	Closed	-$55.4M	–	530
2014 Q1	$55.4M	Sell	791,210 -350,873	-31%	-$24.4M	0.84%	36
2013 Q4	$76.3M	Sell	1,142,083 -599,069	-34%	-$36.6M	1.26%	23
2013 Q3	$90.8M	Buy	1,741,152 +46,276	+3%	+$2.35M	1.46%	14
2013 Q2	$80M	Buy	+1,694,876	New	+$77.4M	1.33%	12

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Analytic Investors's CAH Position: Q3 2016 in Review

Analytic Investors increased its Cardinal Health (CAH) stake by 19% in Q3 2016, buying an estimated $13M and bringing the position to 999,068 shares worth $77.6M. The position accounts for 0.87% of the portfolio, ranked #32.

Analytic Investors first reported a position in CAH in Q2 2013 and has held it in 12 quarters since. The position peaked at $117M in Q3 2015. 771 funds tracked by Wall St. Rank hold CAH as of Q3 2016.

Analytic Investors held 999,068 shares of Cardinal Health worth $77.6M as of Q3 2016.
Analytic Investors bought 161,334 Cardinal Health shares in Q3 2016, an estimated $13M.
Cardinal Health made up 0.87% of Analytic Investors's portfolio in Q3 2016, its #32 holding.
Analytic Investors first reported a position in Cardinal Health in Q2 2013 and has held it in 12 quarters since.
Analytic Investors's Cardinal Health position peaked at $117M in Q3 2015.
771 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.